H. pylori-negative early gastric adenocarcinoma that resembled benign gastritis

Patient Info: Anonymized, male, 40s

A 46-year-old man had a small stomach lesion followed for years as an adenoma before endoscopic removal revealed a well-differentiated gastric adenocarcinoma.

PubMed CentralRead more →

Stage III Inflammatory Breast Cancer: Nikki's Patient Story

Patient Info: Nikki, Female, 40s | Stage III

Biomarkers: Hormone-positive

As of July 2023, Nikki had completed 7 chemotherapy rounds for Stage III inflammatory hormone-positive breast cancer, had no sign of distant spread on PET scans, and was preparing for single mastectomy, radiation, and long-term hormone therapy.

The Patient StoryRead more →

Stage III HER2-Positive Inflammatory Breast Cancer: Nikki's Patient Story

Patient Info: Nikki, Female | Stage III

Biomarkers: HER2-positive; hormone receptor-positive

After 7 chemotherapy rounds, imaging showed no visible disease, but the team expected possible microscopic cancer. A single mastectomy, radiation and long-term hormone therapy were still planned, so she was not classified as cancer-free.

The Patient StoryRead more →

MET-mutated lung cancer: testing savolitinib before surgery

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: MET exon 14 skipping, TP53 and BRAF mutations; PD-L1 expression 5%

Metastatic Site: pleura; mediastinal lymph node

Savolitinib produced a partial radiological response, but surgery confirmed persistent pleural and mediastinal nodal metastases with ypStage IVA disease. He recovered and continued adjuvant savolitinib.

PubMed CentralRead more →

MET-mutated lung cancer: testing savolitinib before surgery — Case 1

Patient Info: Anonymized, Male, 70+

Biomarkers: MET exon 14 skipping mutation

The tumour shrank by 82%; surgery found 5% viable residual tumour and no involved lymph nodes, with postoperative stage ypT2aN0M0. He continued savolitinib without serious adverse effects.

PubMed CentralRead more →

MET-mutated lung cancer: testing savolitinib before surgery — Case 2

Patient Info: Anonymized, Female, 60s

Biomarkers: MET exon 14 skipping mutation; PD-L1 expression 75%

Savolitinib produced approximately 72% tumour shrinkage. Surgery found 30% viable residual tumour, negative lymph nodes and ypT1bN0M0 disease; she recovered without complications and continued savolitinib.

PubMed CentralRead more →

Reconstructive surgery technique fixes tissue death after mastectomy

Patient Info: Anonymized, Female

Biomarkers: Hormone receptor-positive in both breast cancers

The reconstructive wound was completely healed at 2 months, and she continued tamoxifen with ongoing follow-up.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Lucinda's Patient Story

Patient Info: Lucinda Rudolph, Female, 60s

As of June 2023, Lucinda was living well after treatment for locally advanced recurrent invasive lobular breast cancer, taking exemestane, receiving supportive care for neuropathy, and returning to MD Anderson every 6 months for checkups.

MD AndersonRead more →

Colorectal Cancer: Maria's Patient Story

Patient Info: Maria Dupree, Female, 50s

As of June 2023, Maria had recovered well from robotic anterior resection for proximal rectal cancer and had undergone additional chemotherapy; no formal stage, biomarker result, metastatic disease, or NED status is stated.

Cleveland ClinicRead more →

Stage II Invasive Ductal Carcinoma: Cynthia's Survivor Story

Patient Info: Cynthia, Female | Stage II

As of June 2023, Cynthia described herself as cancer-free and about 4 years out from treatment, while continuing normal follow-up and managing survivorship effects including nerve pain, stiffness, and severe fragrance-related skin allergy after radiation.

The Patient StoryRead more →

Cynthia: Stage II Breast Cancer

Patient Info: Cynthia, Female | Stage II

Cynthia completed surgery and 25 rounds of radiation for Stage IIB invasive ductal carcinoma and was about 4 years into survivorship with normal follow-up, ongoing physical effects, and breast cancer education advocacy.

The Patient StoryRead more →

My Colorectal Cancer Story: How I Changed My Diet After Cancer

Patient Info: Angelica Allen, Female, Under 40 | Stage III

As of June 2023, Angelica was all-clear after 5 years following Stage III bowel cancer treatment and described survivorship changes in diet, exercise, rest, stress, and emotional healing.

The Patient StoryRead more →

Stage III Colorectal Cancer: Angelica's Survivor Story

Patient Info: Angelica Allen, Female, Under 40 | Stage III

As of June 2023, Angelica had received her 5-year all-clear after Stage III bowel cancer treatment; later colonoscopy surveillance was reassuring and a liver cyst had disappeared.

The Patient StoryRead more →

Stage II Colorectal Cancer: Wendy's Survivor Story

Patient Info: Wendy Tamis Robbins, 50s | Stage II

Wendy was cancer-free and in surveillance with regular scans and check-ups after surgery and chemotherapy.

Dana-FarberRead more →

Stage III Invasive Lobular Carcinoma: Neda's Survivor Story

Patient Info: Neda, Female, 40s | Stage III

Neda had completed surgery, 24 CMF treatments and 25 radiation treatments. She was regaining energy, had started endocrine therapy and was preparing to add another recurrence-reduction medicine.

Lobular Breast Cancer AllianceRead more →

Stage III Breast Cancer: Sarah's Patient Story

Patient Info: Sarah, Female, 40s | Stage III

Biomarkers: Estrogen/progesterone-sensitive breast cancer mentioned; exact receptor labels not reported

As of June 2023, Sarah had lived through incurable salivary gland cancer and Stage III breast cancer, completed major breast cancer treatment, paused hormone therapy to pursue IVF under medical guidance, delivered her daughter at 48, and was advocating for people with cancer; no cancer-free or NED status was stated.

The Patient StoryRead more →

Stage III HR-Positive Breast Cancer: Sarah's Survivor Story

Patient Info: Sarah McDonald, Female, 40s | Stage III

Biomarkers: ER-positive; PR-positive; HER2-negative

Sarah was 10 years from diagnosis without a recurrence and described the breast cancer as successfully treated. She later paused hormone therapy, completed IVF and gave birth at age 48.

The Patient StoryRead more →

BRCA1 Breast Cancer: Carol's Survivor Story

Patient Info: Carol Arnhart

Biomarkers: BRCA1 mutation

She had a complete pathologic response to breast chemotherapy and later reported no evidence of breast cancer.

MD AndersonRead more →

Stage I BRCA1 Ovarian Cancer: Carol's Survivor Story

Patient Info: Carol Arnhart | Stage I

Biomarkers: BRCA1 mutation

After staging surgery and 6 rounds of carboplatin and paclitaxel, she reported no evidence of ovarian cancer.

MD AndersonRead more →

Stage I Lung Cancer: Terri's Survivor Story

Patient Info: Terri Ann DiJulio, Female, 40s | Stage I

Biomarkers: Not reported for patient; family history of lung cancer noted

As of June 2023, Terri Ann was considered no evidence of disease after 3 early-stage lung cancer diagnoses treated with surgery and SBRT, and she had returned to 6-month follow-up while continuing advocacy and cycling.

The Patient StoryRead more →

Stage II Colorectal Cancer: Stephanie's Survivor Story

Patient Info: Stephanie Tufano, Female, Under 40 | Stage II

As of June 2023, Stephanie had Stage II colon cancer removed surgically, received a clean bill of health, did not need chemotherapy or further treatment, and returned to running, coaching and family life.

Cleveland ClinicRead more →

My Stage 4 Colorectal Cancer Story: How I Never Lost Hope

Patient Info: Jason Randall, Male | Stage IV

Metastatic Site: Liver; lungs; bone/sacrum

As of June 2023, Jason had a negative Signatera test, CT scans showing 9 months with no evidence of disease, and about 2.5 years off chemotherapy after Stage IV colorectal cancer treatment and lung ablation.

The Patient StoryRead more →

Gastric cancer and a large abdominal aortic aneurysm treated in one operation

Patient Info: Anonymized, male, 50s | Stage III

At 1-year follow-up, CT and upper endoscopy showed no local or distant recurrence.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Bart's Survivor Story

Patient Info: Bart Wilson, Male, Under 40 | Stage IV

Metastatic Site: Liver

As of May 2023, Bart had shown no evidence of disease for almost 3 years after surgery, FOLFOX, portal vein embolization, extended right hepatectomy, and adjuvant capecitabine for Stage IV colon cancer with liver metastases.

MD AndersonRead more →